Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin(Tongji Hospital), Dai‐Shi Tian(Tongji Hospital), Ziwei Hu(Tongji Hospital), Ke Ma(Tongji Hospital), Cuihong Xie(Tongji Hospital), Ke Shang(Tongji Hospital), Wei Wang(Tongji Hospital), Tao Yu(Nanfang Hospital), Shuoqi Zhang(Tongji Hospital), Sheng Yang(Fujian Medical University), Luo‐Qi Zhou(Tongji Hospital)
Cited by 5,047
Related Papers
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963
Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release
|Nature Medicine|2011|253
Chemokine CCL2–CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus
|Journal of Neuroscience|2017|214
Advancements and challenges in CAR T cell therapy in autoimmune diseases
|Nature Reviews Rheumatology|2024|203
The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias
|Nature Medicine|2014|200